Seamless Tech Transfer, Predictable Outcomes: Ensuring Success with a dual-site model
When your molecule is ready for the next stage, you need more than a service provider, you need a partner who guarantees a seamless, compliant, and transparent technology transfer. At Rentschler Biopharma, their dual-site model means development projects benefit from global expertise and local execution, ensuring your timelines, quality, and peace of mind are never compromised. In this interview, Dante Lepore, Laboratory Head of Downstream Process Development at CDMO Rentschler Biopharma in Milford, MA, U.S., shares his insights into tech transfer.
Discover the challenges, opportunities, and why technology transfer has become a key factor in biomanufacturing.
In this interview, discover how
- technology transfer is carried out at Rentschler Biopharma,
- cross-functional collaboration becomes a success factor
- digital advancements are shaping the field
- biopharmaceutical companies can benefit from the CDMO’s dual-site approach
Offered Free by: Rentschler Biopharma
See All Resources from: Rentschler Biopharma
